Skip to main content

Table 5 Age ≥ 65 years: eGFR (MDRD) and UACR category prevalence of CKD in T2DM a

From: Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging

GFR category, ml/min/1.73 m2(MDRD) Albuminuria category, mg/g
< 30 30-300 > 300 Rowc
N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI)
G1 ≥ 90 136b 6.5 (5.3-7.7) 71 4.3 (3.2-5.4) 11 0.6 (0.1-1.1) 218 11.4 (9.9-12.9)
G2 60-89 427b 31.7 (28.7-34.8) 168 10.1 (8.1-12.1) 46 2.5 (1.6-3.5) 641 44.4 (40.8-48.0)
G3a 45-59 205 15.8 (13.4-18.2) 116 7.9 (6.2-9.7) 37 2.4 (1.3-3.4) 358 26.1 (22.9-29.3)
G3b 30-44 72 6.1 (4.5-7.7) 66 4.3 (3.1-5.5) 31 2.1 (1.0-3.3) 169 12.5 (10.3-14.8)
G4 15-29 14 0.8 (0.4-1.3) 27 2.6 (1.3-3.9) 28 2.0 (0.9-3.1) 69 5.4 (3.9-6.9)
G5 < 15 d 0.0 (0.0-0.0) d 0.0 (0.0-0.0) 10 0.2 (0.0-0.4) 11 0.2 (0.1-0.4)
Column N, % (95% CI) c 854 60.9 (58.2-63.7) 449 29.3 (26.4-32.2) 163 9.8 (7.5-12.0) 1466 100 (N/A)
  1. aAge adjusted to 2012 NHIS diabetes population.
  2. bDoes not meet CKD criteria based on eGFR or albuminuria.
  3. cSum of rows and columns may deviate due to rounding.
  4. dCell frequency suppressed when count < 3 to avoid potential identifiability and imprecision of estimates.